SKP2 and posterior cortical atrophy: Our findings are in harmony with previous reports that SKP2 has a critical pro-oncogenic function for the development and progression of cancers including PCa, through affiliating oncogenic signaling pathways such as RhoA, c-Myc and Ras [6, 8, 10].